Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Bolt Biotherapeutics (BOLT) Return on Capital Employed (2021 - 2025)

Bolt Biotherapeutics (BOLT) has disclosed Return on Capital Employed for 5 consecutive years, with 0.69% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed rose 14.0% to 0.69% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.69% through Dec 2025, up 14.0% year-over-year, with the annual reading at 0.52% for FY2025, 12.0% up from the prior year.
  • Return on Capital Employed hit 0.69% in Q4 2025 for Bolt Biotherapeutics, up from 0.76% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.23% in Q2 2021 to a low of 0.86% in Q1 2025.
  • Historically, Return on Capital Employed has averaged 0.53% across 5 years, with a median of 0.46% in 2023.
  • Biggest five-year swings in Return on Capital Employed: tumbled -31bps in 2024 and later increased 14bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.31% in 2021, then crashed by -36bps to 0.42% in 2022, then dropped by -22bps to 0.52% in 2023, then tumbled by -59bps to 0.82% in 2024, then increased by 16bps to 0.69% in 2025.
  • Business Quant data shows Return on Capital Employed for BOLT at 0.69% in Q4 2025, 0.76% in Q3 2025, and 0.8% in Q2 2025.